Richard Curry

2.0k total citations
26 papers, 635 citations indexed

About

Richard Curry is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Richard Curry has authored 26 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Neurology and 5 papers in Genetics. Recurrent topics in Richard Curry's work include Glioma Diagnosis and Treatment (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Brain Metastases and Treatment (3 papers). Richard Curry is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Brain Metastases and Treatment (3 papers). Richard Curry collaborates with scholars based in United States, Australia and Philippines. Richard Curry's co-authors include Jeffrey J. Raizer, K. Panageas, Rose Lai, Patrick G. Morris, Lisa M. DeAngelis, Lauren E. Abrey, Gaurav Shah, Anne S. Reiner, Antonio Omuro and Denise D. Correa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Stroke.

In The Last Decade

Richard Curry

24 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Curry United States 11 342 266 262 90 81 26 635
Catherine Han New Zealand 12 168 0.5× 188 0.7× 162 0.6× 170 1.9× 106 1.3× 24 649
Katarzyna Krawczyk Poland 16 49 0.1× 143 0.5× 109 0.4× 76 0.8× 87 1.1× 57 862
Heidi Van Limbergen Belgium 12 52 0.2× 53 0.2× 93 0.4× 128 1.4× 12 0.1× 14 592
Shuguang Liu China 17 54 0.2× 69 0.3× 32 0.1× 136 1.5× 65 0.8× 60 803
Cristina López Spain 19 15 0.0× 287 1.1× 293 1.1× 150 1.7× 88 1.1× 43 908
Zhibo Gao China 11 86 0.3× 133 0.5× 45 0.2× 243 2.7× 64 0.8× 23 734
Maiko Tamura Japan 17 40 0.1× 219 0.8× 84 0.3× 181 2.0× 47 0.6× 32 895
Jian Ding China 12 28 0.1× 49 0.2× 50 0.2× 115 1.3× 166 2.0× 38 594
Gary R. Smerdon United Kingdom 16 41 0.1× 18 0.1× 42 0.2× 94 1.0× 155 1.9× 41 801

Countries citing papers authored by Richard Curry

Since Specialization
Citations

This map shows the geographic impact of Richard Curry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Curry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Curry more than expected).

Fields of papers citing papers by Richard Curry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Curry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Curry. The network helps show where Richard Curry may publish in the future.

Co-authorship network of co-authors of Richard Curry

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Curry. A scholar is included among the top collaborators of Richard Curry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Curry. Richard Curry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desai, Pankaj B., Priyanka Arora, Mario Medvedovic, et al.. (2024). A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas. Clinical Cancer Research. 30(10). 2068–2077. 1 indexed citations
2.
Rixe, Olivier, John L. Villano, Robert Wesolowski, et al.. (2024). A First-in-Human Phase I Study of BXQ-350, a First-in-Class Sphingolipid Metabolism Regulator, in Patients with Advanced/Recurrent Solid Tumors or High-Grade Gliomas. Clinical Cancer Research. 30(22). 5053–5060. 1 indexed citations
3.
4.
5.
Abdelbaki, Mohamed S, Timothy P. Cripe, Richard Curry, et al.. (2022). An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 8(12). e12450–e12450. 2 indexed citations
6.
Fritchie, Karen, Jorge Torres‐Mora, Carrie Y. Inwards, et al.. (2020). Xanthogranulomatous epithelial tumor: report of 6 cases of a novel, potentially deceptive lesion with a predilection for young women. Modern Pathology. 33(10). 1889–1895. 22 indexed citations
7.
Abdelbaki, Mohamed S, Bhuvana A. Setty, Mariko DeWire, Timothy P. Cripe, & Richard Curry. (2020). A pediatric and young adult phase I dose escalation study of BXQ-350 for solid and central nervous system tumors.. Journal of Clinical Oncology. 38(15_suppl). 2541–2541. 2 indexed citations
8.
Rixe, Olivier, John C. Morris, Robert Wesolowski, et al.. (2020). Tolerability and preliminary efficacy of BXQ-350 for refractory solid tumors and high-grade gliomas: First-in-human, first-in-class phase I trial.. Journal of Clinical Oncology. 38(15_suppl). 3505–3505. 1 indexed citations
9.
Rosenthal, Mark, Richard Curry, David A. Reardon, et al.. (2019). Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII. Cancer Chemotherapy and Pharmacology. 84(2). 327–336. 45 indexed citations
10.
Karim, Nagla Abdel, et al.. (2015). Systemic Chemotherapy for Progression of Brain Metastases in Extensive-Stage Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 2015. 1–3. 2 indexed citations
11.
Curry, Richard, Saurabh Dahiya, Vyshak Alva Venur, Jeffrey J. Raizer, & Manmeet S. Ahluwalia. (2015). Bevacizumab in high-grade gliomas: past, present, and future. Expert Review of Anticancer Therapy. 15(4). 387–397. 18 indexed citations
12.
Majd, Nazanin, Kazutaka Sumita, Hirofumi Yoshino, et al.. (2014). A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic. 2014. 1–12. 23 indexed citations
13.
Majd, Nazanin, et al.. (2014). ED-22 * CONCURRENCE OF GLIOMAS IN PATIENTS WITH MULTIPLE SCLEROSIS: CASE REPORT AND LITERATURE REVIEW. Neuro-Oncology. 16(suppl 5). v70–v70. 3 indexed citations
14.
Morris, Patrick G., Denise D. Correa, Joachim Yahalom, et al.. (2013). Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome. Journal of Clinical Oncology. 31(31). 3971–3979. 316 indexed citations
15.
Rahme, Ralph, Richard Curry, Dawn Kleindorfer, et al.. (2011). How Often Are Patients With Ischemic Stroke Eligible for Decompressive Hemicraniectomy?. Stroke. 43(2). 550–552. 37 indexed citations
16.
Kerlinger, Paul, et al.. (2010). Night Migrant Fatalities and Obstruction Lighting at Wind Turbines in North America. The Wilson Journal of Ornithology. 122(4). 744–754. 40 indexed citations
17.
Sauerbeck, Laura, Richard Hornung, Charles J. Moomaw, et al.. (2008). The Effects of Study Participation in the Familial Intracranial Aneurysm Study on Cigarette Smoking. Journal of Stroke and Cerebrovascular Diseases. 17(6). 370–372. 4 indexed citations
18.
Jain, Aaftab, et al.. (2007). Annual Report for the Maple Ridge Wind Power Project Postconstruction Bird and Bat Fatality Study - 2006. 23 indexed citations
19.
Harman‐Fetcho, Jennifer A., Cathleen J. Hapeman, Laura L. McConnell, et al.. (2005). Pesticide Occurrence in Selected South Florida Canals and Biscayne Bay during High Agricultural Activity. Journal of Agricultural and Food Chemistry. 53(15). 6040–6048. 51 indexed citations
20.
Kerlinger, Paul, Richard Curry, & Ronald A. Ryder. (2000). Ponnequin Wind Energy Project: Reference Site Avian Study. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Han Breakdown of academic impact, for papers by Katarzyna Krawczyk Breakdown of academic impact, for papers by Heidi Van Limbergen Breakdown of academic impact, for papers by Shuguang Liu Breakdown of academic impact, for papers by Cristina López Breakdown of academic impact, for papers by Zhibo Gao Breakdown of academic impact, for papers by Maiko Tamura Breakdown of academic impact, for papers by Jian Ding Breakdown of academic impact, for papers by Gary R. Smerdon
Rankless by CCL
2026